The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Fluoxetine-Global Market Insights and Sales Trends 2025
Synopsis
Fluoxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used for the treatment of major depressive disorder, obsessive–compulsive disorder (OCD), bulimia nervosa, panic disorder and premenstrual dysphoric disorder. It may decrease the risk of suicide in those over the age of 65.
The global Fluoxetine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fluoxetine in various end use industries. The expanding demands from the Depression, Obsessive–Compulsive Disorder, Panic Disorder and Bulimia Nervosa, are propelling Fluoxetine market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsules segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Fluoxetine market, driven by demand from China, the second largest economy with some signs of stabilising, the Fluoxetine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Fluoxetine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Fluoxetine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Fluoxetine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Fluoxetine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Fluoxetine covered in this report include Teva, Sun Pharmaceutical, Sandoz, Mylan, Wockhardt, Dr.Reddy's Laboratories, Pharmaceutical Associates Inc., Lannett Company and Aurobindo Pharma, etc.
The global Fluoxetine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Sun Pharmaceutical
Sandoz
Mylan
Wockhardt
Dr.Reddy's Laboratories
Pharmaceutical Associates Inc.
Lannett Company
Aurobindo Pharma
Alembic Pharmaceuticals
Alvogen
Torrent Pharmaceuticals
Suzhou YUSHI Pharmaceutical
Changzhou Siyao Pharmaceutical
Global Fluoxetine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Fluoxetine market, Segment by Type:
Tablets
Capsules
Oral Solution
Global Fluoxetine market, by Application
Depression
Obsessive–Compulsive Disorder
Panic Disorder
Bulimia Nervosa
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Fluoxetine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Fluoxetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Fluoxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used for the treatment of major depressive disorder, obsessive–compulsive disorder (OCD), bulimia nervosa, panic disorder and premenstrual dysphoric disorder. It may decrease the risk of suicide in those over the age of 65.
The global Fluoxetine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fluoxetine in various end use industries. The expanding demands from the Depression, Obsessive–Compulsive Disorder, Panic Disorder and Bulimia Nervosa, are propelling Fluoxetine market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsules segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Fluoxetine market, driven by demand from China, the second largest economy with some signs of stabilising, the Fluoxetine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Fluoxetine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Fluoxetine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Fluoxetine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Fluoxetine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Fluoxetine covered in this report include Teva, Sun Pharmaceutical, Sandoz, Mylan, Wockhardt, Dr.Reddy's Laboratories, Pharmaceutical Associates Inc., Lannett Company and Aurobindo Pharma, etc.
The global Fluoxetine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Sun Pharmaceutical
Sandoz
Mylan
Wockhardt
Dr.Reddy's Laboratories
Pharmaceutical Associates Inc.
Lannett Company
Aurobindo Pharma
Alembic Pharmaceuticals
Alvogen
Torrent Pharmaceuticals
Suzhou YUSHI Pharmaceutical
Changzhou Siyao Pharmaceutical
Global Fluoxetine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Fluoxetine market, Segment by Type:
Tablets
Capsules
Oral Solution
Global Fluoxetine market, by Application
Depression
Obsessive–Compulsive Disorder
Panic Disorder
Bulimia Nervosa
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Fluoxetine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Fluoxetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Fluoxetine Market Overview
1.1 Fluoxetine Product Overview
1.2 Fluoxetine Market Segment by Type
1.2.1 Tablets
1.2.2 Capsules
1.2.3 Oral Solution
1.3 Global Fluoxetine Market Size by Type
1.3.1 Global Fluoxetine Market Size Overview by Type (2018-2029)
1.3.2 Global Fluoxetine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Fluoxetine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Fluoxetine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Fluoxetine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Fluoxetine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Fluoxetine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Fluoxetine Sales Breakdown by Type (2018-2023)
2 Global Fluoxetine Market Competition by Company
2.1 Global Top Players by Fluoxetine Sales (2018-2023)
2.2 Global Top Players by Fluoxetine Revenue (2018-2023)
2.3 Global Top Players by Fluoxetine Price (2018-2023)
2.4 Global Top Manufacturers Fluoxetine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Fluoxetine Market Competitive Situation and Trends
2.5.1 Fluoxetine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Fluoxetine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fluoxetine as of 2022)
2.7 Date of Key Manufacturers Enter into Fluoxetine Market
2.8 Key Manufacturers Fluoxetine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Fluoxetine Status and Outlook by Region
3.1 Global Fluoxetine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Fluoxetine Historic Market Size by Region
3.2.1 Global Fluoxetine Sales in Volume by Region (2018-2023)
3.2.2 Global Fluoxetine Sales in Value by Region (2018-2023)
3.2.3 Global Fluoxetine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Fluoxetine Forecasted Market Size by Region
3.3.1 Global Fluoxetine Sales in Volume by Region (2024-2029)
3.3.2 Global Fluoxetine Sales in Value by Region (2024-2029)
3.3.3 Global Fluoxetine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Fluoxetine by Application
4.1 Fluoxetine Market Segment by Application
4.1.1 Depression
4.1.2 Obsessive–Compulsive Disorder
4.1.3 Panic Disorder
4.1.4 Bulimia Nervosa
4.1.5 Others
4.2 Global Fluoxetine Market Size by Application
4.2.1 Global Fluoxetine Market Size Overview by Application (2018-2029)
4.2.2 Global Fluoxetine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Fluoxetine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Fluoxetine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Fluoxetine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Fluoxetine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Fluoxetine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Fluoxetine Sales Breakdown by Application (2018-2023)
5 North America Fluoxetine by Country
5.1 North America Fluoxetine Historic Market Size by Country
5.1.1 North America Fluoxetine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Fluoxetine Sales in Volume by Country (2018-2023)
5.1.3 North America Fluoxetine Sales in Value by Country (2018-2023)
5.2 North America Fluoxetine Forecasted Market Size by Country
5.2.1 North America Fluoxetine Sales in Volume by Country (2024-2029)
5.2.2 North America Fluoxetine Sales in Value by Country (2024-2029)
6 Europe Fluoxetine by Country
6.1 Europe Fluoxetine Historic Market Size by Country
6.1.1 Europe Fluoxetine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Fluoxetine Sales in Volume by Country (2018-2023)
6.1.3 Europe Fluoxetine Sales in Value by Country (2018-2023)
6.2 Europe Fluoxetine Forecasted Market Size by Country
6.2.1 Europe Fluoxetine Sales in Volume by Country (2024-2029)
6.2.2 Europe Fluoxetine Sales in Value by Country (2024-2029)
7 Asia-Pacific Fluoxetine by Region
7.1 Asia-Pacific Fluoxetine Historic Market Size by Region
7.1.1 Asia-Pacific Fluoxetine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Fluoxetine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Fluoxetine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Fluoxetine Forecasted Market Size by Region
7.2.1 Asia-Pacific Fluoxetine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Fluoxetine Sales in Value by Region (2024-2029)
8 Latin America Fluoxetine by Country
8.1 Latin America Fluoxetine Historic Market Size by Country
8.1.1 Latin America Fluoxetine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Fluoxetine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Fluoxetine Sales in Value by Country (2018-2023)
8.2 Latin America Fluoxetine Forecasted Market Size by Country
8.2.1 Latin America Fluoxetine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Fluoxetine Sales in Value by Country (2024-2029)
9 Middle East and Africa Fluoxetine by Country
9.1 Middle East and Africa Fluoxetine Historic Market Size by Country
9.1.1 Middle East and Africa Fluoxetine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Fluoxetine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Fluoxetine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Fluoxetine Forecasted Market Size by Country
9.2.1 Middle East and Africa Fluoxetine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Fluoxetine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Teva
10.1.1 Teva Company Information
10.1.2 Teva Introduction and Business Overview
10.1.3 Teva Fluoxetine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Teva Fluoxetine Products Offered
10.1.5 Teva Recent Development
10.2 Sun Pharmaceutical
10.2.1 Sun Pharmaceutical Company Information
10.2.2 Sun Pharmaceutical Introduction and Business Overview
10.2.3 Sun Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sun Pharmaceutical Fluoxetine Products Offered
10.2.5 Sun Pharmaceutical Recent Development
10.3 Sandoz
10.3.1 Sandoz Company Information
10.3.2 Sandoz Introduction and Business Overview
10.3.3 Sandoz Fluoxetine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sandoz Fluoxetine Products Offered
10.3.5 Sandoz Recent Development
10.4 Mylan
10.4.1 Mylan Company Information
10.4.2 Mylan Introduction and Business Overview
10.4.3 Mylan Fluoxetine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mylan Fluoxetine Products Offered
10.4.5 Mylan Recent Development
10.5 Wockhardt
10.5.1 Wockhardt Company Information
10.5.2 Wockhardt Introduction and Business Overview
10.5.3 Wockhardt Fluoxetine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Wockhardt Fluoxetine Products Offered
10.5.5 Wockhardt Recent Development
10.6 Dr.Reddy's Laboratories
10.6.1 Dr.Reddy's Laboratories Company Information
10.6.2 Dr.Reddy's Laboratories Introduction and Business Overview
10.6.3 Dr.Reddy's Laboratories Fluoxetine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Dr.Reddy's Laboratories Fluoxetine Products Offered
10.6.5 Dr.Reddy's Laboratories Recent Development
10.7 Pharmaceutical Associates Inc.
10.7.1 Pharmaceutical Associates Inc. Company Information
10.7.2 Pharmaceutical Associates Inc. Introduction and Business Overview
10.7.3 Pharmaceutical Associates Inc. Fluoxetine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Pharmaceutical Associates Inc. Fluoxetine Products Offered
10.7.5 Pharmaceutical Associates Inc. Recent Development
10.8 Lannett Company
10.8.1 Lannett Company Company Information
10.8.2 Lannett Company Introduction and Business Overview
10.8.3 Lannett Company Fluoxetine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Lannett Company Fluoxetine Products Offered
10.8.5 Lannett Company Recent Development
10.9 Aurobindo Pharma
10.9.1 Aurobindo Pharma Company Information
10.9.2 Aurobindo Pharma Introduction and Business Overview
10.9.3 Aurobindo Pharma Fluoxetine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Aurobindo Pharma Fluoxetine Products Offered
10.9.5 Aurobindo Pharma Recent Development
10.10 Alembic Pharmaceuticals
10.10.1 Alembic Pharmaceuticals Company Information
10.10.2 Alembic Pharmaceuticals Introduction and Business Overview
10.10.3 Alembic Pharmaceuticals Fluoxetine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Alembic Pharmaceuticals Fluoxetine Products Offered
10.10.5 Alembic Pharmaceuticals Recent Development
10.11 Alvogen
10.11.1 Alvogen Company Information
10.11.2 Alvogen Introduction and Business Overview
10.11.3 Alvogen Fluoxetine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Alvogen Fluoxetine Products Offered
10.11.5 Alvogen Recent Development
10.12 Torrent Pharmaceuticals
10.12.1 Torrent Pharmaceuticals Company Information
10.12.2 Torrent Pharmaceuticals Introduction and Business Overview
10.12.3 Torrent Pharmaceuticals Fluoxetine Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Torrent Pharmaceuticals Fluoxetine Products Offered
10.12.5 Torrent Pharmaceuticals Recent Development
10.13 Suzhou YUSHI Pharmaceutical
10.13.1 Suzhou YUSHI Pharmaceutical Company Information
10.13.2 Suzhou YUSHI Pharmaceutical Introduction and Business Overview
10.13.3 Suzhou YUSHI Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Suzhou YUSHI Pharmaceutical Fluoxetine Products Offered
10.13.5 Suzhou YUSHI Pharmaceutical Recent Development
10.14 Changzhou Siyao Pharmaceutical
10.14.1 Changzhou Siyao Pharmaceutical Company Information
10.14.2 Changzhou Siyao Pharmaceutical Introduction and Business Overview
10.14.3 Changzhou Siyao Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Changzhou Siyao Pharmaceutical Fluoxetine Products Offered
10.14.5 Changzhou Siyao Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Fluoxetine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Fluoxetine Industrial Chain Analysis
11.4 Fluoxetine Market Dynamics
11.4.1 Fluoxetine Industry Trends
11.4.2 Fluoxetine Market Drivers
11.4.3 Fluoxetine Market Challenges
11.4.4 Fluoxetine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Fluoxetine Distributors
12.3 Fluoxetine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
